Literature DB >> 10571289

The 1998 Castroviejo Lecture. New strategies in the treatment of dry-eye states.

M A Lemp1.   

Abstract

PURPOSE: To review developments in dry-eye research leading to new therapeutic possibilities and to suggest a prioritizing schema.
METHODS: New development in our understanding of the pathogenesis, diagnoses, and treatment of dry-eye states have been reviewed along with the possible impact on new therapeutic approaches.
RESULTS: A variety of approaches to the pathogenesis and degrees of dry-eye states have emerged, giving rise to significant new approaches to the treatment of these disorders.
CONCLUSION: There are now new treatment possibilities. Ranking their development based on their fundamental reversal of disease mechanisms seems a reasonable approach with early therapeutic pay-off.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571289     DOI: 10.1097/00003226-199911000-00001

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  4 in total

Review 1.  Eye complaints in the office environment: precorneal tear film integrity influenced by eye blinking efficiency.

Authors:  P Wolkoff; J K Nøjgaard; P Troiano; B Piccoli
Journal:  Occup Environ Med       Date:  2005-01       Impact factor: 4.402

2.  Activities of autonomic neurotransmitters in Meibomian gland tissues are associated with menopausal dry eye.

Authors:  Lianxiang Li; Dongling Jin; Jinsheng Gao; Liguang Wang; Xianjun Liu; Jingzhang Wang; Zhongxin Xu
Journal:  Neural Regen Res       Date:  2012-12-15       Impact factor: 5.135

3.  Effects of Nickel at Environmentally Relevant Concentrations on Human Corneal Epithelial Cells: Oxidative Damage and Cellular Apoptosis.

Authors:  Zhen-Ning Zhang; Hai Liu; Mi-Mi Liu; Dan-Lei Yang; Jue Bi; Qian-Qian Chen; Wei Chen; Ping Xiang
Journal:  Biomolecules       Date:  2022-09-12

4.  The function and morphology of Meibomian glands in patients with thyroid eye disease: a preliminary study.

Authors:  Chia-Yu Wang; Ren-Wen Ho; Po-Chiung Fang; Hun-Ju Yu; Chun-Chih Chien; Chang-Chun Hsiao; Ming-Tse Kuo
Journal:  BMC Ophthalmol       Date:  2018-04-12       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.